BioNTech SE (BNTX) Current Assets (2018 - 2025)

BioNTech SE has disclosed Current Assets across 8 years of filings, most recently posting $18.8 billion for Q4 2025.

• Current Assets for Q4 2025 came in at $18.8 billion, down 6.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $18.8 billion (down 6.46% YoY), and the FY2025 annual result was $18.2 billion, down 9.21% from the prior year.
• Current Assets came in at $18.8 billion for Q4 2025 at BioNTech SE, up from $18.5 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $22.4 billion in Q4 2022 to a low of $4.3 billion in Q1 2021.
• The 5-year median for Current Assets is $20.0 billion (2024), against an average of $18.5 billion.
• Across the five-year window, Current Assets soared 1385.59% in 2021 and declined 17.21% in 2025, its largest moves.
• BioNTech SE's Current Assets stood at $17.2 billion in 2021, then advanced by 29.72% to $22.4 billion in 2022, then retreated by 6.06% to $21.0 billion in 2023, then decreased by 4.36% to $20.1 billion in 2024, then declined by 6.46% to $18.8 billion in 2025.
• The last three Current Assets figures came in at $18.8 billion (Q4 2025), $18.5 billion (Q3 2025), and $18.0 billion (Q2 2025), per Business Quant data.